Hepatology
From the Journals
Hepatitis Outlook: Late February 2017
Why does HCV continue to be one of leading blood-borne infections in Europe? Read about this and other notable hepatitis news in our regular...
From the Journals
HCV ‘cure’ within the VA appears likely
The VA has removed barriers to treatment and allocated funds for the costly but effective drugs to treat HCV.
From the Journals
Infant hepatitis B vaccine protection lingers into adolescence
Does lack of residual hepatitis B virus antibodies from vaccines mean lack of protection?
From the Journals
HCV testing stagnant among baby boomers
Rates of hepatitis C virus testing in baby boomers rose only slightly between 2013 and 2015, despite calls for universal testing.
From the Journals
Hepatitis outlook: early February 2017
Hepatitis C–infected patients with decompensated cirrhosis receiving direct-acting antivirals present lower response rates and experience more...
From the Journals
In beta thalassemia major, liver stiffness declines with deferasirox
For patients with beta thalassemia major, long-term chelation with deferasirox led to significant improvements in liver stiffness.
From the Journals
VIDEO: Point-of-care assay caught acetaminophen toxicity
A novel competitive serum immunoassay accurately identified cases of acetaminophen-induced acute liver toxicity.
Practice Alert
ACIP vaccine update, 2017
HIV infection is now an indication for meningococcus vaccination and HPV vaccine dosing is simpler for patients <15 years.
From the Journals
Hepatitis Outlook: January 2017
Strong evidence exists that Western health professionals miss opportunities for hepatitis B virus testing and vaccination of Chinese migrant...
Conference Coverage
ACR guidelines on HBV screening called inadequate
SNOWMASS, COLO. The selective screening of patients for HBV in the 2015 ACR guidelines for treatment of rheumatoid arthritis should be skipped in...
From the Journals
Biannual HCC ultrasound cost-effective, lifesaving in cirrhosis
Guideline-directed ultrasound liver cancer screening boosts survival in cirrhosis patients.